peptic ulcers Flashcards
rational drug design - James Black
involves understanding the natural ligands that might regulate a receptor cell surface receptor and then changing the structure of those molecules to either increase the potency or Effectiveness or to block the receptor.
- . These are known as antagonists.
- you don’t really need to know what the receptor is. You don’t need to know the molecular identity of the receptor. You just need to know what the structure of the ligand is that induces that response
- and then you modify the structure of the chemistry of that to try and get better drugs, better ligands that will either block the receptor or activate the receptor with greater potency.
- And that strategy is used multiple times during this discovery process and he’s used it in a similar way for the discovery of drugs used to treat peptic ulcers
marshalls discovery
discovered that peptic ulcers were actually caused by a bacterial infection helicobacter bacteria
- and this completely changed the whole sort of field of peptic ulcers and it took many years for that Discovery to kind of reach a consensus and he was often regarded as a bit of a quack
- over the years his theory gained prominence
the stomach
- You’ve got the fundus the Corpus and the Antrim
- and then you’ve got the pylorus which allows all the contents of the stomach to go into the duodenum
-and there are different cells located in these different regions of the stomach
major cells types of the stomach that are involved in gastric secretion
- parietal cells - the secrete hydrochloric acid. They also secrete intrinsic factor.
- The chief cells secrete pepsinogen. This is a digestive enzyme that breaks down proteins.
- You’ve also got G cells which are an Endocrine cells that secrete gastrin and gastrin has an important role in control of gastric acid secretion.
- enterochromaffin cells and they secrete histamine and that has an important role in the control of acid secretion
and all of these are effectively some of the targets for some of the drugs that were
developed for the treatment of peptic ulcer
control of gastric secretion - gastrin
the cells that secrete acid are the parietal cells.
○ this is controlled by gastrin that is secreted from the G cells within the stomach and that gastrin is a hormone that activates a receptor that is very similar to cholecystokinin receptor.
○ It’s a slightly different receptor and those tend to be expressed on the pancreatic acinar cells that secrete digestive enzymes.
control of gastric secretion - nerve cells
- You’ve also got nerve cells that secrete acetyl choline, which is the major neurotransmitter that controls acid secretion.
○ So for example, during the sort of smell and and sight of food you start your stomach starts rumbling, and that’s mainly caused by your nervous system, which is the parasympathetic nervous system which controls the secretion of gastric acid
○ And so acetyl choline activates the muscarinic receptor on the parietal cells and that’s important for secretion of acid,
control of gastric secretion - enterochromaffin cells
- So even though there are gastrin receptors on the parietal cells and muscarinic receptors on the parietal cells, The major mechanism for controlling acid secretion comes from the secretion of histamine from the enterochromaffin cells.
- And it’s the histamine That’s the major driving force and the major control mechanism for acid secretion
. If you remove that histamine, then the acid secretion is reduced to a minimum and a minimum control by gastrin and acetylcholine
activation of tubular vesicles
you’ve got these tubular vesicles that have a very high surface area, but then once activated by histamine or acetyl choline or gastrin these all activate these various G protein-coupled receptors that increase intracellular calcium.
- So they activate G proteins that couple to G Alpha q that then activates phospholipase C and the phospholipase C converts phosphoinositol bisphosphate into IP 3 and diacylglycerol
- and the ip3 activates calcium release from the endoplasmic reticulum.
- And you get this huge increase in calcium and that calcium activates the secretion of of acid
- and likewise cAMP coupled to G alpha s mediated G proteins is also involved in the control of acid secretion
and once activated these tubular vesicles become these canaliculi and these have a huge surface area now and once they are activated there is a six to ten fold increase in the number of these proton pumps that are on the apical surface. and this increases massively increases the amount of acid that gets secreted.
ulcer
acid/ enzyme damage to stomach or intestinal wall
- 10% europeans and north americans affected
- complications: GI bleeding, perforation
if theres a perforation acid can leak out, you can have a major bleed and if that perforation goes through the entire duodenal wall then all of that acid will ne leaking out into the peritoneum
- until1970s required surgery
H2 antagonists
- cimetidine was the first line H2 antagonist for the treatment of ulcers and the structure is kind of similar to histamine
- identified by design e.g. compounds with structural motifs similar to histamine
- And this provided a classification of the histamine receptors because up until that time they didn’t really know what the drug targets were.
The control of acid secretion is very specifically H2 receptors and the H2 receptors are only expressed in the stomach. So they have a very specific role and therefore drugs that act at these are unlikely to effect H1 receptors and control allergies,
how do H2 antagonists work
they work in humans because histamine is the major mechanism for controlling acid secretion
- the major driving force for controlling acid secretion is histamine.
- And the activation of H2 receptors, so blocking that with an antagonist, is a very effective way at controlling acid secretion.
H2 receptor antagonist drugs
- cimetidine
- ramatidine
- market huge = success for UK pharma in the 70s and 80s
- H2 antagonists still used = OTC indigestion relief and in pain relief often co-administered with NSAIDs
- late 1980s expiration of patent for H2 antagonists = opened market for new drugs
potential anti ulcer drug targets
- muscarinic ACh = side effects
- gastrin receptors = no success
-ion channels and transporters
- K+ channels
- Cl- channels- H+-K+ ATPase
proton pump inhibitors
so there was a huge drive to develop proton pump inhibitors and these were discovered
in the early 70s,
- an accidental Discovery because there was this search for gastrin receptor antagonists and there was a class of drug known as the thioamide which affected acid secretion
- and these were developed because they were thought to be gastrin antagonist, but further scrutiny of the mechanism realized that these were not affecting gastrin receptors, but we’re doing something else but they were very effective at reducing acid secretion
- and by 1977. it was disocvered That this proton pump was responsible for the effects of these thioamides
- meant that you could now use that as a structural backbone to develop more specific drugs that were inhibiting the proton pump and nothing else
omeprazole - 1st generation proton pump inhibitor
- lipid soluble (so gets absorbed in GI tract) , weak base - enters and accumulates in acid spaces (canaliculi of parietal cell)
- activated in acid (so its a prodrug) - chemically altered by H+ to an active sulphenamide form
- IC50 = 50 nM (means its very potent)
- forms irreversible S-S bond with H+ - K+ ATPase